MedTrace Logo

Freestyle Libre Use in Real Life: Efficacy and Acceptance

NCT03703999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-03-27

No results posted yet for this study

Summary

Aim of the study is to evaluate efficacy of freestyle Libre system (flash glucose monitoring) in real life in term of Glycated Haemoglobin reduction and acceptance of the system evaluated through validated questionnaires after 3 and 6 months of device's use.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

Type 1 diabetic patients freestyle libre

patients selected to use freestyle libre

Sponsors & Collaborators

  • University of Padova

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-04-01
Completion
2019-09-01
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03703999 on ClinicalTrials.gov